Health

  • January 08, 2026

    Cooley-Led Eir Partners Wraps $1B Health Tech Fund

    Cooley LLP-advised private equity shop Eir Partners Capital LP on Thursday announced that it wrapped its third fund with $1 billion of investor commitments, which will be used to invest in health technology and technology-enabled services businesses.

  • January 08, 2026

    Trump Admin Can't Undo Block On Drug Rebate Program

    A First Circuit panel has refused to lift a district judge's block on a Trump administration plan to pilot a rebate model for a federal drug discount program that benefits low-income patients, saying the federal government is unlikely to win its appeal.

  • January 08, 2026

    Husch Blackwell Expands With 18-Person Immigration Team

    Husch Blackwell LLP has hired an 18-person immigration team made up of two lawyers, eight paralegals and eight business professionals from an Illinois boutique, the firm announced this week.

  • January 07, 2026

    Steptoe Adds Ex-Fed. Prosecutor To White Collar Team In LA

    Steptoe LLP has hired Jamari Buxton, a veteran federal prosecutor with extensive experience investigating public corruption and civil rights issues with the U.S. Attorney's Office for the Central District of California, to be a partner in the firm's White-Collar Defense & Compliance practice in Los Angeles. 

  • January 07, 2026

    Biotech Co. Says HHS Infringed Patent With Moderna Vax Deal

    A biotech company that developed a patented protein technology that allegedly expedited the development of Moderna's COVID-19 Spikevax vaccine sued the U.S. Department of Health and Human Services on Wednesday, claiming the feds infringed its patent through a contract to develop a vaccine with the pharma giant.

  • January 07, 2026

    Amazon Seeks To Halt Supplement Suit As FDA Nixes Rule

    Amazon called on a Seattle federal judge to pause a proposed class action accusing the e-commerce platform of failing to make certain disclosures on supplement product pages, saying the U.S. Food and Drug Administration plans to revoke the so-called each panel labeling rule at the center of the case.

  • January 07, 2026

    Genesis Cleared For New Ch. 11 Auction And Stalking Horse

    Nursing home operator Genesis Healthcare may hold a new Chapter 11 auction with a fresh stalking horse offer worth nearly $1 billion, a Texas bankruptcy judge ruled Wednesday, a month after she nixed the results of its previous auction.

  • January 07, 2026

    United Workers' Revamped Vax Suit Can Proceed, Judge Says

    Workers suing United Airlines over its COVID-19 vaccine mandate, which they allege violated federal discrimination law, are allowed to amend their more than 700-page lawsuit, a Texas federal court has ruled, despite the airline decrying the move as a delay tactic.

  • January 07, 2026

    Vets Allege Firm's Data Breach Jeopardizes Private Info

    A Pennsylvania law firm that handles veterans' Social Security and VA disability claims is facing proposed class claims over a November data breach that potentially affected the private health and financial information of thousands of clients. 

  • January 07, 2026

    Fla. Notice To Medicaid Enrollees Is Inadequate, Judge Says

    A Florida federal judge has found that the state's notices to residents cutting their Medicaid coverage "border on the incomprehensible" and violate the residents' due process by depriving them of a chance to challenge the decision.

  • January 07, 2026

    Ga. Health Clinic, Ex-Aide Reach Deal In Wage Fight

    A Georgia mental health clinic and a former aide have reached a tentative agreement that, if approved, would end the ex-aide's suit alleging she was forced to resign last year after the clinic refused to hand over thousands in unpaid overtime.

  • January 07, 2026

    New Mexico Nursing Facility Files Ch. 11

    The operator of a 369-bed skilled nursing facility in Albuquerque, New Mexico, has filed for Chapter 11 protection in a Florida bankruptcy court with more than $1 million in debt and has been granted joint administration with its already-bankrupt management affiliate.

  • January 07, 2026

    Potomac Law Adds Former DOJ, HHS Civil Rights Atty

    Potomac Law Group has hired a healthcare attorney with over 15 years working on LGBTQ+ protections and other civil rights issues at the Justice Department and the Department of Health and Human Services.

  • January 07, 2026

    Healthpeak Tees Up IPO Plans For Senior Housing REIT

    Healthpeak Properties Inc. said Wednesday it submitted plans to regulators for the formation of a real estate investment trust dedicated to senior housing and the launching of an initial public offering for the company.

  • January 07, 2026

    Firm In 'Maya' Verdict Seeks Coverage For Spinoff Fee Row

    The firm that secured a $213 million award in favor of Maya Kowalski, the person at the center of the Netflix documentary "Take Care of Maya," told a Florida federal court that its professional liability insurer owed coverage for a spinoff suit involving trial consultant fees. 

  • January 07, 2026

    Detroit Pension Fund Wins 'Close' Call To Lead Investor Suit

    A Detroit pension fund should lead a proposed shareholder class action against MoonLake Immunotherapeutics, though a competing bid by a France-based lab worker and screenwriter alleges a "marginally larger" investment loss, a Manhattan federal judge has determined.

  • January 07, 2026

    Covenant Health Sued Over Patient Data Security Breach

    Nonprofit healthcare system Covenant Health Inc. has been hit with a proposed class action over a data breach that reportedly compromised the information of nearly half a million people.

  • January 07, 2026

    FDA Pushes Back On Vape Cos.' 5th Circ. Appeal

    The U.S. Food and Drug Administration is urging the Fifth Circuit to reject a group of appeals from e-cigarette manufacturers seeking to overturn the marketing denial of their flavored vapes, saying the agency did not abuse its discretion in rejecting the companies' products.

  • January 06, 2026

    8th Circ. Revives Jail Suicide Suit Against Mental Health Org.

    An Eighth Circuit panel unanimously revived a lawsuit Tuesday by the family of an Iowa jail inmate who died by suicide, holding that a jury could find that a mental health provider's alleged incomplete report to jail staff put the inmate at greater risk.  

  • January 06, 2026

    Judge Hints Conn. Dentist's Press Release Claims Lack Teeth

    A Connecticut appellate judge seemed to doubt Tuesday that a dentist had asserted clear constitutional claims against state officials who issued a press release about his $300,000 False Claims Act settlement, suggesting the case might actually sound in defamation.

  • January 06, 2026

    Bankrupt Hospital Wants Out Of $3B BCBS Antitrust Deal

    A bankrupt Alabama hospital is asking a federal judge to allow it to drop out of a $2.8 billion antitrust class action settlement with Blue Cross Blue Shield, saying it may be forced to shut down unless it can pursue separate relief in bankruptcy court.

  • January 06, 2026

    Cigna Accused Of Rigging Market For Life-Saving Drugs

    Patients with chronic health conditions sued Cigna in an Illinois federal court alleging in a proposed class action Tuesday that the company and its pharmacy and pharmacy benefit manager subsidiaries use exclusive agreements to lock users into a network where Byzantine refill processes have been deliberately erected to limit payouts for life-saving drugs.

  • January 06, 2026

    FTC Signals Support Of Miss. Bill For Midwives' Solo Practice

    A Federal Trade Commission official on Monday encouraged a Mississippi lawmaker to keep in mind the possible motives of opponents of proposed legislation that would exempt midwives from having to contract with physicians to provide advanced-level nursing care.

  • January 06, 2026

    FDA To Ease Regulation Of Wearables, Decision Software

    U.S. Food and Drug Administration Commissioner Marty Makary touted new federal guidance on Tuesday that he said would promote innovation by making it easier to bring certain kinds of wearable devices and clinical-decision software to market without a strict regulatory review.

  • January 06, 2026

    GAO IDs 4 Funding Programs As Lacking Fraud Controls

    The U.S. Government Accountability Office has identified four federal agency funding programs as having failed to incorporate certain key requirements and leading practices meant to oversee and prevent fraud, waste and abuse in awards. 

Expert Analysis

  • Trump's 2nd Term Puts Merger Remedies Back On The Table

    Author Photo

    In contrast with the Biden administration, the second Trump administration has signaled a renewed willingness to resolve merger enforcement concerns through remedies from the outset, particularly when the proposed fix is structural, clearly addresses the harm and does not require burdensome oversight, say attorneys at Cooley.

  • Patent Ambiguity Persists After Justices Nix Eligibility Appeal

    Author Photo

    The Supreme Court recently declined to revisit the contentious framework governing patent eligibility by denying certiorari in Audio Evolution Diagnostics v. U.S., suggesting a necessary recalibration of both patent application and litigation strategies, say attorneys at Skadden.

  • Texas Med Spas Must Prepare For 2 New State Laws

    Author Photo

    Two new laws in Texas — regulating elective intravenous therapy and reforming healthcare noncompetes — mark a pivotal shift in the regulatory framework for medical spas in the state, which must proactively adapt their operations and contractual practices, says Brad Cook at Munsch Hardt.

  • Series

    Playing Soccer Makes Me A Better Lawyer

    Author Photo

    Soccer has become a key contributor to how I approach my work, and the lessons I’ve learned on the pitch about leadership, adaptability, resilience and communication make me better at what I do every day in my legal career, says Whitney O’Byrne at MoFo.

  • Strategies For Cos. Navigating US-Indian Pharma Partnerships

    Author Photo

    Recent policy adjustments implemented by the U.S. government present both new opportunities and heightened regulatory scrutiny for the Indian life sciences industry, amplifying the importance of collaboration between the Indian and U.S. pharmaceutical sectors, say Bryant Godfrey at Foley Hoag and Jashaswi Ghosh at Holon Law Partners.

  • DOJ-HHS Collab Crystallizes Focus On Health Enforcement

    Author Photo

    The recently announced partnership between the U.S. Department of Justice and U.S. Department of Health and Human Services to combat False Claims Act violations, following a multiyear trend of high-dollar DOJ recoveries, signals a long-term enforcement horizon with major implications for healthcare entities and whistleblowers, say attorneys at RJO.

  • Series

    Law School's Missed Lessons: Learning From Failure

    Author Photo

    While law school often focuses on the importance of precision, correctness and perfection, mistakes are inevitable in real-world practice — but failure is not the opposite of progress, and real talent comes from the ability to recover, rethink and reshape, says Brooke Pauley at Tucker Ellis.

  • How The Healthline Privacy Settlement Redefines Ad Tech Use

    Author Photo

    The Healthline settlement is the first time California has drawn a clear line in the sand around how website tracking must function in practice, so if your site uses tracking technologies, especially around sensitive content like health or finance, regulators are inspecting your website's back end, not just its banner, say attorneys at Baker Donelson.

  • How Sweeping Budget Bill Shakes Up Health Industry

    Author Photo

    With the recently passed One Big Beautiful Bill Act marking one of the most significant overhauls of federal health policy since the passage of the Affordable Care Act, providers, managed care organizations and life sciences companies must now shift focus from policy review to implementation planning, say advisers at Holland & Knight.

  • Series

    Adapting To Private Practice: From ATF Director To BigLaw

    Author Photo

    As a two-time boomerang partner, returning to BigLaw after stints as a U.S. attorney and the director of the Bureau of Alcohol, Tobacco, Firearms and Explosives, people ask me how I know when to move on, but there’s no single answer — just clearly set your priorities, says Steven Dettelbach at BakerHostetler.

  • New DOJ Penalty Policy Could Spell Trouble For Cos.

    Author Photo

    In light of the U.S. Department of Justice’s recently published guidance making victim relief a core condition of coordinated resolution crediting, companies facing parallel investigations must carefully calibrate their negotiation strategies to minimize the risk of duplicative penalties, say attorneys at Debevoise.

  • A Look At Key 5th Circ. White Collar Rulings So Far This Year

    Author Photo

    In the first half of 2025, the Fifth Circuit has decided numerous cases of particular import to white collar practitioners, which collectively underscore the critical importance of meticulous recordbuilding, procedural compliance and strategic litigation choices at every stage of a case, says Joe Magliolo at Jackson Walker.

  • High Court Cert Spotlights Varying Tests For Federal Removal

    Author Photo

    A recent decision by the U.S. Supreme Court to review Chevron v. Plaquemines Parish, a case involving the federal officer removal statute, highlights three other recent circuit court decisions raising federal removal questions, and serves as a reminder that defendants are the masters of removal actions, says Varun Aery at Hollingsworth.

  • Series

    Playing Baseball Makes Me A Better Lawyer

    Author Photo

    Playing baseball in college, and now Wiffle ball in a local league, has taught me that teamwork, mental endurance and emotional intelligence are not only important to success in the sport, but also to success as a trial attorney, says Kevan Dorsey at Swift Currie.

  • What US Medicine Onshoring Means For Indian Life Sciences

    Author Photo

    Despite the Trump administration's latest moves to onshore essential medicine manufacturing, India will likely remain an indispensable component of the U.S. drug supply chain, but Indian manufacturers should prepare for stricter compliance checks, says Jashaswi Ghosh at Holon Law Partners.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.